Expanding Into Clinical Trials

Liquids & Semisolids

What Makes a Great Liquid Oral Dose CDMO?

Rob Terry

TriRx Pharmaceutical Services

Pathfinder

Basket vs. Umbrella Clinical Trials: Which Precision Oncology Trial Design Is Better?

Pharma's Almanac

LAI Formulation

The Formulation Science Behind Extended Drug Release

Pharma's Almanac

Pathfinder

Adaptive Trials vs. Traditional Randomized Controlled Trials: Which Clinical Trial Design Is Better?

Pharma's Almanac

Basket Trials

Basket Trials and the Future of Rare Cancer Research

David Alvaro, Ph.D.

Pharma's Almanac

Organoids

Data-Centric Organoid Services for Predictive Drug Response and Next-Generation Oncology Research

Seahee Kim, Ph.D.

Samsung Biologics

Outsourcing

Do you expect continued movement away from one-stop-shop outsourcing toward deeper modality-specific expertise?

Pharma's Almanac

Pathfinder

Site-Based vs. Decentralized vs. Hybrid Clinical Trials: Which Model Is Best for Modern Clinical Research?

Pharma's Almanac

Tech Transfer

Why Successful Scale-Up and Transfer Capabilities Increasingly Determine Outsourcing Success

Pharma's Almanac

LNP Strategy

Building Better RNA Medicines Through Smarter LNP Formulation Strategy

Aula Al Muslim, Ph.D.

Recipharm Advanced Bio

U.S. CDMO Capacity

More Than Capacity: What the Latest U.S. CDMO Expansion Wave Reveals About Specialized Manufacturing Demand

Pharma's Almanac